PetDx, Inc.
- Sep 1, 2021 · D · $45,699,512 sold of $62,193,617 · 103 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
- Jul 9, 2021 · D/A · $11,765,000 sold of $13,000,000 · 2 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗
- Jan 5, 2021 · D · $207,500 sold of $10,000,000 · 2 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗
- Aug 13, 2020 · D · $9,240,000 sold of $11,610,000 · 90 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
- Mar 3, 2020 · D/A · $2,375,000 sold of $6,000,000 · 42 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
- Sep 23, 2019 · D · $1,120,000 sold of $2,000,000 · 23 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
Raised $45.7M from 103 investors (73% of the $62.2M target) as of the latest filing. Daniel is listed as executive officer, director on 6 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.